Emma Flett > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Emma Flett
Work Department
Technology & IP Transactions
Position
Emma L. Flett is a partner in Kirkland’s Technology & IP Transactions Practice and heads the London team. Emma’s practice is focused on complex intellectual property and technology-related transactions, carve-outs and business separations and EU data protection.
Career
2010 to present Kirkland & Ellis International LLP; 2007-2010 Clifford Chance LLP
Memberships
Society for Computers and Law
International Association of Privacy Professionals
Emma is a member of the Firmwide Gender & Diversity Committee, the European Associate Review Committee, the Firmwide Pro Bono Committee, and London Office Operations Committee
Education
University of Cambridge (M.A. (Cantab) (Law and Management), 2008); Oxford Institute of Legal Practice (Legal Practice Course, 2006); Judge Business School, University of Cambridge (Second Part II (Management), 2005); Christ’s College, University of Cambridge (B.A., Cantab (Law), 2005)
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
‘Top-class’ Kirkland & Ellis International LLP maintains a strong IP offering, routinely handling high-stakes disputes, one notable example being the team’s representation of Pfizer and Regeneron in landmark judgments in the Supreme Court. The team of ‘ferocious litigators’ also has experience of handling SEP/FRAND related litigation. On the transactional side, the team is involved in M&A deals, as well as multiple asset deals and carve-out transactions. Nicola Dagg spearheads the IP litigation practice, she has a wealth of experience in managing biotech patent litigations, as well as an expertise in emerging SEP/FRAND related work. Daniel Lim is noted for his ability to handle complex multijurisdictional patent litigation, often involving blockbuster life sciences and medical devices related matters, while IP litigator Steven Baldwin is well-versed in the high-tech and life sciences sectors. ‘Strategic thinker’ Jin Ooi fields a strong IP litigation practice, with his expertise in the biotechnology space. Emma Flett leads the firm’s technology and IP transactions team with her capabilities that encompass the full gamut of IP-related work, but especially in regard to high-value M&A transactions.
London > Industry focus > Life sciences and healthcare
Kirkland & Ellis International LLP houses a ‘talented and experienced‘ team, which is noted for its strength in IP disputes, follow on damages cases, and M&A. Daniel Lim, ‘titan of IP litigation‘ Nicola Dagg, and Emma Flett jointly lead the practice. ‘Top-class litigator‘ Lim acts for a clients in disputes concerning medical devices and pharmaceutical products, often in relation to commercial launches and injunctions. Hailed by clients as ‘one of the outstanding patent litigators of current times‘, Dagg regularly defends patents against challenges from generics manufacturers. Litigator Jin Ooi has broad expertise in small molecule, DNA sequencing, and transgenic animal platform issues, displaying ‘laser sharp focus‘ when arbitrating trade secrets disputes in the medical devices space. Since publication, Katie Coltart has moved to Linklaters LLP.
Lawyer Rankings
- Intellectual property: patents (contentious and non-contentious) London > TMT (technology, media and telecoms)
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium